{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:20:33Z","timestamp":1792344033514,"version":"4.4.0"},"reference-count":127,"publisher":"Baishideng Publishing Group Inc.","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2016]]},"DOI":"10.3748\/wjg.v22.i4.1650","type":"journal-article","created":{"date-parts":[[2016,1,24]],"date-time":"2016-01-24T22:31:43Z","timestamp":1453674703000},"page":"1650","source":"Crossref","is-referenced-by-count":37,"title":["Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon"],"prefix":"10.3748","volume":"22","author":[{"given":"Sara","family":"Belga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"World Health Organization. Hepatitis C: Fact sheet NO164. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"www.who.int\/mediacentre\/factsheets\/fs164\/en\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.who.int\/mediacentre\/factsheets\/fs164\/en\/<\/ext-link>."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2010.03432.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26141"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i6.885"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Chan SE, Schwartz JM, Rosen HR. Treatment of hepatitis C in solid organ transplantation. Drugs 2004;64:489-498.","DOI":"10.2165\/00003495-200464050-00003"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840170103"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80279-7"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2003.12.030"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-139X.2005.18108.x"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00649.x"},{"key":"ref11","unstructured":"Liu YB, Xie JZ, Zhong CJ, Liu K. Hepatitis C virus infection among hemodialysis patients in Asia: a meta-analysis. Eur Rev Med Pharmacol Sci 2014;18:3174-3182."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.15.1843"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(98)00053-9"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000055831.63841.B6"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199110000-00013"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2000.17951"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510290123"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199701150-00029"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/gast.2002.36610"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199803150-00011"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2005.00918.x"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.01.003"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/lt.500050417"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199602150-00008"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199811150-00023"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)01503-7"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181f92548"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.5"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2009.00926.x"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199808270-00010"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199510000-00007"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2004.00252.x"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200208270-00001"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/593291"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2010060668"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1086\/315355"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2005.05.006"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000100127.54107.57"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2004.00652.x"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(03)00717-6"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2006.08.025"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3181e17032"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2012.03.024"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2009.12.061"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(03)00148-7"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e3182193cd3"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2012.04112.x"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2007.01.037"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00493-9"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.06.014"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Honaker MR, Stratta RJ, Lo A, Egidi MF, Shokouh-Amiri MH, Grewal HP, Alloway RR, Gaber LW, Hardinger KL, Gaber AO. Impact of hepatitis C virus status in pancreas transplantation: a case controlled study. Clin Transplant 2002;16:243-251.","DOI":"10.1034\/j.1399-0012.2002.01116.x"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2006.00534.x"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2008.00831.x"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i1.55"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.02.004"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2008.81"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12108"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2008.00990.x"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.11.003"},{"key":"ref60","unstructured":"Alavian SM, Tabatabaei SV. Meta-analysis of factors associated with sustained viral response in patients on hemodialysis treated with standard or pegylated interferon for hepatitis C infection. Iran J Kidney Dis 2010;4:181-194."},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.01981.x"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2010.06488.x"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2012.10.009"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2013.08.133"},{"key":"ref65","unstructured":"American Association for the Study of Liver Diseases (AASLD)\/Infectious Diseases Society of America (IDSA)\/International Antiviral Society (IAS)-USA. Recommendations for testing, managing, and treating hepatitis C. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hcvguidelines.org\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hcvguidelines.org\/<\/ext-link>."},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Myers RP, Shah H, Burak KW, Cooper C, Feld JJ. An update on the management of chronic hepatitis C: 2015 Consensus guidelines from the Canadian Association for the Study of the Liver. Can J Gastroenterol Hepatol 2015;29:19-34.","DOI":"10.1155\/2015\/692408"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/lt.21694"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318273fec4"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Fattovich G, Giustina G, Favarato S, Ruol A. A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon. J Hepatol 1996;24:38-47.","DOI":"10.1016\/S0168-8278(96)80184-X"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2009.09.084"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Kim EY, Ko HH, Yoshida EM. A concise review of hepatitis C in heart and lung transplantation. Can J Gastroenterol 2011;25:445-448.","DOI":"10.1155\/2011\/947838"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/01.tp.0000264561.18380.22"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2013.729577"},{"key":"ref75","unstructured":"Janssen. Simeprevir (galexos(r)) product monograph. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.janssen.com\/canada\/sites\/www_janssen_com_canada\/files\/product\/pdf\/gal01292015cpm_snds.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.janssen.com\/canada\/sites\/www_janssen_com_canada\/files\/product\/pdf\/gal01292015cpm_snds.pdf<\/ext-link>."},{"key":"ref76","unstructured":"AbbVie. Viekira pak&trade;, with or without ribavirin (rbv), is indicated for the treatment of adult patients with genotype 1 chronic hepatitis c virus infection, including those with compensated cirrhosis. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.abbvie.com\/content\/dam\/abbviecorp\/us\/desktop\/contentrooms\/downloads\/ProductFactsheet_ViekiraPak_US.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.abbvie.com\/content\/dam\/abbviecorp\/us\/desktop\/contentrooms\/downloads\/ProductFactsheet_ViekiraPak_US.pdf<\/ext-link>."},{"key":"ref77","unstructured":"Gilead. Sovaldi (r) product monograph. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/liver-disease\/harvoni\/harvoni_pi.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/liver-disease\/harvoni\/harvoni_pi.pdf<\/ext-link>."},{"key":"ref78","unstructured":"Bristol-Myers Squibb. Prescribing information for daklinza (daclatasvir). 2014. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.medicines.org.uk\/emc\/medicine\/29129\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.medicines.org.uk\/emc\/medicine\/29129<\/ext-link>."},{"key":"ref79","unstructured":"AbbVie. A study to evaluate the efficacy, safety, and pharmacokinetics of co-administration of abt-493 and abt-530 with and without ribavirin in subjects with hcv genotype 1, 4, 5, and 6 infection. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02243280\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/clinicaltrials.gov\/ct2\/show\/NCT02243280<\/ext-link>."},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.05.010"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70050-2"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.09.023"},{"key":"ref83","unstructured":"Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.natap.org\/2014\/AASLD\/AASLD_16.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.natap.org\/2014\/AASLD\/AASLD_16.htm<\/ext-link>."},{"key":"ref84","unstructured":"Ledipasvir\/sofosbuvir with ribavirin is safe and efficacious in decompensated and post-liver transplant patients with hcv infection: Preliminary results of the solar-2 trial. Proceedings of the Program and abstracts of the 50th Annual Meeting of the European Association for the Study of the Liver; 2015 April 18-22. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.natap.org\/2015\/EASL\/EASL_27.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.natap.org\/2015\/EASL\/EASL_27.htm<\/ext-link>."},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.05.030"},{"key":"ref86","unstructured":"Daclatasvir, sofosbuvir, and ribavirin combination for hcv patients with advanced cirrhosis or post-transplant recurrence: Ally-1 phase 3 study. Proceedings of the Program and abstracts of the 50th Annual Meeting of the European Association for the Study of the Liver; 2015 April 22-16. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.natap.org\/2015\/EASL\/EASL_56.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.natap.org\/2015\/EASL\/EASL_56.htm<\/ext-link>."},{"key":"ref87","unstructured":"Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.natap.org\/2015\/EASL\/EASL_49.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.natap.org\/2015\/EASL\/EASL_49.htm<\/ext-link>."},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2013.09.013"},{"key":"ref89","unstructured":"Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.natap.org\/2014\/AASLD\/AASLD_02.htm\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.natap.org\/2014\/AASLD\/AASLD_02.htm<\/ext-link>."},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30167-7"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30158-6"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1109\/embc.2014.6943588"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12714"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402338"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27890"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27826"},{"key":"ref97","unstructured":"Huard G, Kim B, Patel A, Aljarallah B, Perumalswami P, Odin A, Geatrakas S, Ahmad J, Dieterich D, Nair V. E. Early safety and efficacy profiles of renal transplant recipients with chronic hepatitis c treated with sofosbuvir and ribavirin. Hepatology 2014;60:117A."},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12622"},{"key":"ref99","unstructured":"Gane E, Robson R, Bonacini M, Maliakkal B, Liu L, Sajwani K, Stamm LM, Brainard D, McHutchison J, Stedman C. Safety, anti-viral efficacy and pharmacokinetics (pk) of sofosbuvir (sof) in patients with severe renal impairment. Hepatology 2014;60:133A."},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30147-1"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(15)30155-0"},{"key":"ref102","unstructured":"eMedFusion. Drug interaction chart. 2015. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.hep-druginteractions.org\/\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.hep-druginteractions.org\/<\/ext-link>."},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13111"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209243271302"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)90583-9"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(00)00062-0"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1016\/S1053-2498(98)00019-9"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.11.008"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.04.056"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2011.01.148"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000090743.43034.72"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000034944.90425.75"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1046\/j.1600-6143.2004.00606.x"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03091.x"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316366"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402454"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402355"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1315722"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61036-9"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1401726"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27726"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1316145"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27487"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27588"},{"key":"ref126","unstructured":"Ledipasvir\/sofosbuvir treatment results in high svr rates in patients with chronic genotype 4 and 5 hcv infection Proceedings of the 2015 International Liver Congress: 50th Annual Meeting of the European Association for the Study of the Liver (EASL) 2015; 62 Suppl 2: S219-S220. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"onlinelibrary.wiley.com\/doi\/10.1002\/hep.v62.S1\/issuetoc\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hep.v62.S1\/issuetoc<\/ext-link>."},{"key":"ref127","unstructured":"Gilead. Prescribing information for harvoni (ledipasvir and sofosbuvir). 2014. Available from: <ext-link ext-link-type=\"uri\" xlink:href=\"http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/liver-disease\/harvoni\/harvoni_pi.pdf\" xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\">http:\/\/www.gilead.com\/~\/media\/Files\/pdfs\/medicines\/liver-disease\/harvoni\/harvoni_pi.pdf<\/ext-link>."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1650.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T19:54:13Z","timestamp":1567540453000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v22\/i4\/1650.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v22.i4.1650","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}